Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.86)
# 83
Out of 5,093 analysts
43
Total ratings
76.74%
Success rate
24.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRKR Marker Therapeutics | Initiates: Buy | $10 | $1.45 | +589.66% | 1 | Dec 8, 2025 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $23.83 | +151.78% | 3 | Dec 3, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $80 → $85 | $66.99 | +26.88% | 3 | Dec 2, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $55 | $38.45 | +43.04% | 2 | Nov 24, 2025 | |
| ONCY Oncolytics Biotech | Maintains: Buy | $5 → $10 | $0.97 | +933.54% | 1 | Nov 17, 2025 | |
| CYBN Cybin | Maintains: Buy | $150 → $55 | $5.71 | +863.22% | 1 | Nov 14, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Buy | $30 → $25 | $4.31 | +480.05% | 2 | Nov 12, 2025 | |
| GHRS GH Research | Maintains: Buy | $40 → $35 | $14.46 | +142.13% | 1 | Nov 10, 2025 | |
| QURE uniQure | Maintains: Buy | $110 → $70 | $20.76 | +237.19% | 5 | Nov 4, 2025 | |
| IVVD Invivyd | Maintains: Buy | $5 → $10 | $2.54 | +293.70% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $13.12 | +281.10% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $36.85 | +171.37% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.51 | +117.79% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $2.19 | +1,730.66% | 3 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $36.01 | +38.87% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $26.89 | +197.51% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $410.13 | +38.98% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.37 | +243.25% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.25 | +1,100.00% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.68 | +124.55% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $79.07 | +7.51% | 2 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $11.01 | +354.08% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.49 | +1,955.50% | 1 | Sep 4, 2025 |
Marker Therapeutics
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Pharvaris
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $23.83
Upside: +151.78%
Arrowhead Pharmaceuticals
Dec 2, 2025
Maintains: Buy
Price Target: $80 → $85
Current: $66.99
Upside: +26.88%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $38.45
Upside: +43.04%
Oncolytics Biotech
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.97
Upside: +933.54%
Cybin
Nov 14, 2025
Maintains: Buy
Price Target: $150 → $55
Current: $5.71
Upside: +863.22%
Voyager Therapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $4.31
Upside: +480.05%
GH Research
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $14.46
Upside: +142.13%
uniQure
Nov 4, 2025
Maintains: Buy
Price Target: $110 → $70
Current: $20.76
Upside: +237.19%
Invivyd
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $2.54
Upside: +293.70%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $13.12
Upside: +281.10%
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $36.85
Upside: +171.37%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $5.51
Upside: +117.79%
Oct 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.19
Upside: +1,730.66%
Oct 14, 2025
Reiterates: Buy
Price Target: $50
Current: $36.01
Upside: +38.87%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $26.89
Upside: +197.51%
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $410.13
Upside: +38.98%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $4.37
Upside: +243.25%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $6.25
Upside: +1,100.00%
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $6.68
Upside: +124.55%
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $79.07
Upside: +7.51%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $11.01
Upside: +354.08%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.49
Upside: +1,955.50%